Since, in cancers, the NF‐кB pathway and activation of STAT3 are closely linked [39, 40], we evaluated the activation of NF‐κB and the IKKα/β status in CRC cells treated with DCZ0415. The gene discussed is NFKB1; the disease is cancer.